Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Conditions
Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified · Recurrent Primary Mediastinal Large B-Cell Lymphoma · Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma · Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified · Refractory Primary Mediastinal Large B-Cell Lymphoma · Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope Medical Center, Duarte, California, United States
Contact: Principal Investigator (Geoffrey Shouse)City of Hope Atlanta Cancer Center, Newnan, Georgia, United States
Contact: Principal Investigator (Geoffrey Shouse)City of Hope at Chicago, Zion, Illinois, United States
Contact: Principal Investigator (Geoffrey Shouse)
Study leads
Geoffrey Shouse
Principal Investigator
City of Hope Medical Center